Marc Maliepaard

Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.

Marc Maliepaard, George L. Scheffer, Ian F. Faneyte et al. · PubMed · 2001 · 1.1K citations

Breast Oncology, Immunology, Subcellular Localization +20

Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

Marc Maliepaard, M A van Gastelen, L A de Jong et al. · PubMed · 1999 · 487 citations

Chemoprevention Strategy, Pathology, Cancer Biology +18

Frequent expression of the multi‐drug resistance‐associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP‐21 monoclonal antibody in paraffin‐embedded material

Julio E. Diestra, George L. Scheffer, Isabel Català et al. · The Journal of Pathology · 2002 · 273 citations

Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camptothecins in vitro using non-substrate drugs or the BCRP inhibitor GF120918.

Marc Maliepaard, Margôt A. van Gastelen, Akiko Tohgo et al. · PubMed · 2001 · 234 citations

Breast Oncology, Chemoprevention Strategy, Bcrp-mediated Resistance +17

The HER tyrosine kinase inhibitor CI1033 enhances cytotoxicity of 7-ethyl-10-hydroxycamptothecin and topotecan by inhibiting breast cancer resistance protein-mediated drug efflux.

Charles Erlichman, Scott A. Boerner, Christopher G. Hallgren et al. · PubMed · 2001 · 222 citations

Tumor Biology, Breast Oncology, Oncology +15